Asmaa M. Zahran
- Hematology top 5%
- Blood groups and transfusion 10
- Immunology top 10%
- Immune Cell Function and Interaction 23
- T-cell and B-cell Immunology 13
- Immunotherapy and Immune Responses 11
- Immune cells in cancer 8
- Genetics top 10%
- Diabetes and associated disorders 7
- Reproductive Medicine top 10%
-
- Cancer Immunotherapy and Biomarkers 10
-
- COVID-19 Clinical Research Studies 8
- Co-authors
- Khalid I. ElsayhHelal F. HettaKhaled SaadOmnia El‐BadawyAmal RayanEmad A. TahaAmira ElhoufeyAzza Elkady
- Cited by
- HematologyImmunologyGenetics
- Journals
- Scientific Reports (6 papers)Archivum Immunologiae et Therapiae Experimentalis (6 papers)Pediatric Research (4 papers)
- Partner nations
- EgyptSaudi ArabiaUnited States
In The Last Decade
Asmaa M. Zahran
120 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Hematology 212
- Immunology 389
- Genetics 129
- Reproductive Medicine 79
- Cancer Research 128
Countries citing papers authored by Asmaa M. Zahran
This map shows the geographic impact of Asmaa M. Zahran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asmaa M. Zahran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asmaa M. Zahran more than expected).
Fields of papers citing papers by Asmaa M. Zahran
This network shows the impact of papers produced by Asmaa M. Zahran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asmaa M. Zahran. The network helps show where Asmaa M. Zahran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Asmaa M. Zahran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 6 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 8 | |
| 10 | 2020 | 19 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 18 | |
| 14 | 2020 | 28 | |
| 15 | Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma. | 2018 | 17 |
| 16 | Flow Cytometry Analysis of DNA Ploidy and S-Phase Fraction in Salivary Gland Tumors of Egyptian Patients | 2018 | 6 |
| 17 | 2018 | 8 | |
| 18 | 2016 | 8 | |
| 19 | 2012 | 14 | |
| 20 | Effectiveness of carthamus tinctorius L. in the restitution of lipid composition in irradiated rats | 2007 | 2 |
About Asmaa M. Zahran
Asmaa M. Zahran is a scholar working on Hematology, Immunology and Genetics, having authored 129 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (13 papers), Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Blood groups and transfusion (10 papers), COVID-19 Clinical Research Studies (8 papers), Immune cells in cancer (8 papers) and Diabetes and associated disorders (7 papers). The work is most often cited by research in Hematology (212 citations), Immunology (389 citations) and Genetics (129 citations). Asmaa M. Zahran has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Khalid I. Elsayh, Helal F. Hetta, Khaled Saad, Omnia El‐Badawy, Amal Rayan, Emad A. Taha, Amira Elhoufey, Azza Elkady, Mohamed A. Mekky and Kotb Abbass Metwalley. Their work appears in journals such as Scientific Reports, Archivum Immunologiae et Therapiae Experimentalis, Pediatric Research, Cancer Biomarkers and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.